A lethal cancer knocked down by one-two drug punch, The Jackson Laboratory, June 7, 2009
'The researchers found that CML did not develop in mice without Alox5 because of impaired function of leukemia stem cells. Also, Alox5 deficiency did not affect normal stem cell function, providing the first clear differentiation between normal and cancer stem cells. '
http://www.jax.org/news/archives/2009/c ... rough.html
Cure possible for one type of leukemia, Bangor Daily New, Maine, June 2009
'A physician and researcher affiliated with The Jackson Laboratory in Bar Harbor says he may have identified a cure for the most common form of human leukemia. '
http://www.bangordailynews.com/detail/108012.html
A lethal cancer knocked down by one-two drug punch, The Jackson Laboratory, June 2009
'Li also treated mice with CML with Zileuton, an asthma medication that inhibits the Alox5 inflammation pathway, as well imatinib, commonly known as Gleevec, the most effective current leukemia medication. Imatinib effectively treated CML, but Zileuton was more effective. The two drugs combined provided an even better therapeutic effect.'
http://www.eurekalert.org/pub_releases/ ... 060509.php
Combination Drug Therapy Effective for Lethal Cancer, June 2009
'A combination of Zileuton and Gleevec could be a potent treatment for chronic myeloid leukemia (CML), researchers have revealed'
http://www.medindia.net/news/view_news_main.asp?x=52634
Now, a one-two drug punch approach to KO a lethal cancer, Londres, June 2009
http://www.newstrackindia.com/printnews/105178
http://www.thelondonnews.net/story/507644
http://www.newkerala.com/nkfullnews-1-52187.html